Shearman & Sterling advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Barclays Bank PLC and J.P. Morgan Securities LLC as joint lead arrangers and joint bookrunning managers in connection with a $5 billion term loan related to Amgen Inc.’s $10.5 billion purchase of Onyx Pharmaceuticals Inc. Concurrently, the firm also represented Bank of America, N.A. in connection with a $3.1 billion sale and repurchase agreement financing transaction related to the acquisition.
The cross-border, cross-practice Shearman & Sterling team included partners Bjorn Bjerke (New York-Finance), Maura O’Sullivan (New York-Finance), Etienne Gelencser (Tokyo-Project Development & Finance), Alfred Groff (Washington, DC-Tax), Andrew Tenzer (New York-Bankruptcy & Reorganization), John Wilson (San Francisco-Capital Markets), and William Yaro (New York-Finance); of counsel Kevin Dolan (Washington, DC-Tax); counsel Richard Gagnon (Washington, DC-Tax), Susan Hobart (New York-Finance), Sharon Lippett (New York-Executive Compensation & Employee Benefits), Jung-Kyu McCann (New York-Capital Markets), and Jobie Shally (New York-Litigation); and associates Temi Adeniji (New York-Corporate), Bejide Davis (New York-Corporate), Brandon Douglass (New York-Finance), Elizabeth Fluke (New York-Corporate), Caitlyn Gale (New York-Investment Funds), Stacey Jeffreys (London-Mergers & Acquisitions), Nathan Mee (San Francisco-Capital Markets), Katerina Rainwood (London-Finance), Nathan Tasso (Washington, DC-Tax) and Barbara Zylberg (New York-Finance).
